More Company News

Arecor Therapeutics

Q122 results
09 May 2022Read More

Arecor Therapeutics

CRL for surufatinib from US FDA
02 May 2022Read More

Arecor Therapeutics

FY21 results
28 Apr 2022Read More

Arecor Therapeutics

AT278 Phase I data at ATTD
28 Apr 2022Read More

Arecor Therapeutics

RXC004 data to be presented at ASCO
27 Apr 2022Read More

Arecor Therapeutics

FY21 results
26 Apr 2022Read More

Arecor Therapeutics

Final FY21 financial results
25 Apr 2022Read More

Arecor Therapeutics

Data at WAO-BSACI
25 Apr 2022Read More

Arecor Therapeutics

Parsortix poster presented at AACR
14 Apr 2022Read More

Arecor Therapeutics

AffyXell JV milestone and increased equity stake
13 Apr 2022Read More

1 2 3 4 … 74
Return to Arecor Therapeutics
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).